Straumann Holding AG (OTCMKTS:SAUHY) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have received an average recommendation of “Hold” from the seven analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company.

SAUHY has been the topic of several recent research reports. BMO Capital Markets started coverage on Straumann in a report on Wednesday, July 8th. They issued an “outperform” rating on the stock. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft lowered shares of Straumann from a “buy” rating to a “hold” rating in a research note on Friday, August 21st. Barclays reiterated an “overweight” rating on shares of Straumann in a research report on Thursday, June 18th. Finally, Citigroup reissued a “sell” rating on shares of Straumann in a research note on Thursday, July 9th.

Straumann Price Performance

OTCMKTS SAUHY opened at $11.55 on Tuesday. Straumann has a 52 week low of $9.44 and a 52 week high of $13.61. The stock has a fifty day moving average of $12.45 and a 200-day moving average of $11.66.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.